Cargando…

Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes

BACKGROUND: NKX6.1 is a transcription factor for insulin, as well as a marker for β cell maturity. Abnormal NKX6.1 expression in β cells, such as translocation from the nucleus to cytoplasm or lost expression, has been shown as a marker for β cell dedifferentiation. METHODS: We obtained pancreatic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tengli, Sun, Peng, Zou, Jiaqi, Wang, Le, Wang, Guanqiao, Liu, Na, Liu, Yaojuan, Ding, Xuejie, Zhang, Boya, Liang, Rui, Wang, Shusen, Shen, Zhongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955633/
https://www.ncbi.nlm.nih.gov/pubmed/33711989
http://dx.doi.org/10.1186/s12902-021-00708-7
_version_ 1783664283473674240
author Liu, Tengli
Sun, Peng
Zou, Jiaqi
Wang, Le
Wang, Guanqiao
Liu, Na
Liu, Yaojuan
Ding, Xuejie
Zhang, Boya
Liang, Rui
Wang, Shusen
Shen, Zhongyang
author_facet Liu, Tengli
Sun, Peng
Zou, Jiaqi
Wang, Le
Wang, Guanqiao
Liu, Na
Liu, Yaojuan
Ding, Xuejie
Zhang, Boya
Liang, Rui
Wang, Shusen
Shen, Zhongyang
author_sort Liu, Tengli
collection PubMed
description BACKGROUND: NKX6.1 is a transcription factor for insulin, as well as a marker for β cell maturity. Abnormal NKX6.1 expression in β cells, such as translocation from the nucleus to cytoplasm or lost expression, has been shown as a marker for β cell dedifferentiation. METHODS: We obtained pancreatic sections from organ donors and immunofluorescence staining with NKX6.1 and insulin was performed to characterize NKX6.1 expression in subjects with or without type 2 diabetes mellitus (T2DM). RESULTS: Our results showed that cells with insulin expression but no nucleic NKX6.1 expression (NKX6.1(Nuc-)Ins(+)), and cells with cytoplasmic NKX6.1 expression but no insulin expression (NKX6.1(cyt)Ins(−)) were significantly increased in T2DM subjects and positively correlated with glycated hemoglobin (HbA1c), indicating the elevated β cell dedifferentiation with NKX6.1 inactivation in T2DM. To investigate whether β cell dedifferentiation has initiated in subjects with higher risks for T2DM, we next analyzed the association between β-cell dedifferentiation level in ND subjects with different ages, body mass index, and HbA1c. The results showed the absolute number and percentage of dedifferentiated β cells with NKX6.1 inactivation did not significantly change in subjects with advanced aging, obesity, or modest hyperglycemia, indicating that the β cell dedifferentiation might mainly occur after T2DM was diagnosed. CONCLUSION: Our results suggested that NKX6.1 expression in β cells was changed in type 2 diabetic subjects, evidenced by significantly increased NKX6.1(Nuc-)Ins(+) and NKX6.1(cyt)Ins(−) cells. This abnormality did not occur more frequently in subjects with a higher risk for T2DM, suggesting that β cell dedifferentiation might be secondary to the pathological changes in T2DM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00708-7.
format Online
Article
Text
id pubmed-7955633
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79556332021-03-15 Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes Liu, Tengli Sun, Peng Zou, Jiaqi Wang, Le Wang, Guanqiao Liu, Na Liu, Yaojuan Ding, Xuejie Zhang, Boya Liang, Rui Wang, Shusen Shen, Zhongyang BMC Endocr Disord Research Article BACKGROUND: NKX6.1 is a transcription factor for insulin, as well as a marker for β cell maturity. Abnormal NKX6.1 expression in β cells, such as translocation from the nucleus to cytoplasm or lost expression, has been shown as a marker for β cell dedifferentiation. METHODS: We obtained pancreatic sections from organ donors and immunofluorescence staining with NKX6.1 and insulin was performed to characterize NKX6.1 expression in subjects with or without type 2 diabetes mellitus (T2DM). RESULTS: Our results showed that cells with insulin expression but no nucleic NKX6.1 expression (NKX6.1(Nuc-)Ins(+)), and cells with cytoplasmic NKX6.1 expression but no insulin expression (NKX6.1(cyt)Ins(−)) were significantly increased in T2DM subjects and positively correlated with glycated hemoglobin (HbA1c), indicating the elevated β cell dedifferentiation with NKX6.1 inactivation in T2DM. To investigate whether β cell dedifferentiation has initiated in subjects with higher risks for T2DM, we next analyzed the association between β-cell dedifferentiation level in ND subjects with different ages, body mass index, and HbA1c. The results showed the absolute number and percentage of dedifferentiated β cells with NKX6.1 inactivation did not significantly change in subjects with advanced aging, obesity, or modest hyperglycemia, indicating that the β cell dedifferentiation might mainly occur after T2DM was diagnosed. CONCLUSION: Our results suggested that NKX6.1 expression in β cells was changed in type 2 diabetic subjects, evidenced by significantly increased NKX6.1(Nuc-)Ins(+) and NKX6.1(cyt)Ins(−) cells. This abnormality did not occur more frequently in subjects with a higher risk for T2DM, suggesting that β cell dedifferentiation might be secondary to the pathological changes in T2DM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00708-7. BioMed Central 2021-03-12 /pmc/articles/PMC7955633/ /pubmed/33711989 http://dx.doi.org/10.1186/s12902-021-00708-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liu, Tengli
Sun, Peng
Zou, Jiaqi
Wang, Le
Wang, Guanqiao
Liu, Na
Liu, Yaojuan
Ding, Xuejie
Zhang, Boya
Liang, Rui
Wang, Shusen
Shen, Zhongyang
Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title_full Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title_fullStr Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title_full_unstemmed Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title_short Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
title_sort increased frequency of β cells with abnormal nkx6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955633/
https://www.ncbi.nlm.nih.gov/pubmed/33711989
http://dx.doi.org/10.1186/s12902-021-00708-7
work_keys_str_mv AT liutengli increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT sunpeng increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT zoujiaqi increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT wangle increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT wangguanqiao increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT liuna increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT liuyaojuan increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT dingxuejie increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT zhangboya increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT liangrui increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT wangshusen increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes
AT shenzhongyang increasedfrequencyofbcellswithabnormalnkx61expressionintype2diabetesbutnotinsubjectswithhigherriskfortype2diabetes